These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2206850
21. Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry. Okunieff P, Vaupel P, Sedlacek R, Neuringer LJ. Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1493-500. PubMed ID: 2498241 [Abstract] [Full Text] [Related]
22. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts. Guichard M, Lespinasse F, Trotter M, Durand R, Chaplin D. Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087 [Abstract] [Full Text] [Related]
24. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Beauregard DA, Thelwall PE, Chaplin DJ, Hill SA, Adams GE, Brindle KM. Br J Cancer; 1998 Jun; 77(11):1761-7. PubMed ID: 9667644 [Abstract] [Full Text] [Related]
33. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor. Constantinidis I, Gamcsik MP. Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):143-9. PubMed ID: 7642412 [Abstract] [Full Text] [Related]
34. In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia. Vaupel P, Okunieff P, Neuringer LJ. Int J Hyperthermia; 1990 Aug 30; 6(1):15-31. PubMed ID: 2299228 [Abstract] [Full Text] [Related]
35. Differences in vascular response between primary and transplanted tumours. Field SB, Needham S, Burney IA, Maxwell RJ, Coggle JE, Griffiths JR. Br J Cancer; 1991 May 30; 63(5):723-6. PubMed ID: 1645562 [Abstract] [Full Text] [Related]